Fu Siyi, Zhu Hui, Li Siyi, Wang Yalong, Bei Yihua, Xiao Junjie
Regeneration and Ageing Lab, Experimental Center of Life Sciences and Innovative Drug Research Center, School of Life Science, Shanghai University, 333 Nan Chen Road, Shanghai 200444, China.
Curr Stem Cell Res Ther. 2016;11(5):390-4. doi: 10.2174/1574888x1105160509234231.
Telocytes (TCs) are a distinct type of stromal cells with extremely thin and long prolongations called telopodes (Tps). TCs have been ubiquitously reported in almost all tissues and organs across species including heart. TCs are distinct from fibroblasts as evidenced by ultrastructural characteristics, immunohistochemistry features, gene profiles, proteome features, and miRNA signatures. By means of heterocellular junctions and extracellular vesicles, TCs may be able to regulate cardiac stem cells, angiogenesis, and anti-fibrosis. Therapeutic effects of cardiac TCs in myocardium infarction have been demonstrated. Cardiac TCs could be a source of cardiac repair and protection.
间充质干细胞(TCs)是一种独特的基质细胞类型,具有极细且长的延伸部分,称为端粒(Tps)。在包括心脏在内的几乎所有物种的所有组织和器官中,均广泛报道了间充质干细胞。间充质干细胞与成纤维细胞不同,超微结构特征、免疫组织化学特征、基因谱、蛋白质组特征和微小RNA特征均证明了这一点。通过异细胞连接和细胞外囊泡,间充质干细胞可能能够调节心脏干细胞、血管生成和抗纤维化。已经证明了心脏间充质干细胞在心肌梗死中的治疗作用。心脏间充质干细胞可能是心脏修复和保护的来源。